CERo Therapeutics Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CANTOR FITZGERALD, L. P. | 05/15/2025 | 441.05 K | $6.40 K | 0.00% | 12.87% |
| MMCAP INTERNATIONAL INC. SPC | 05/12/2025 | 375.00 K | $5.44 K | 0.00% | 10.94% |
| SABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 295.91 K | $3.77 K | 0.00% | 8.63% |
| PERISCOPE CAPITAL INC. | 05/13/2025 | 274.00 K | $3.97 K | 0.00% | 7.99% |
| CLEAR STREET DERIVATIVES LLC | 05/15/2025 | 268.13 K | $3.89 K | 0.00% | 7.82% |
| LINDEN ADVISORS LP | 05/15/2025 | 250.00 K | $3.33 K | 0.00% | 7.29% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 224.93 K | $2.25 K | 0.00% | 6.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 192.87 K | $2.80 K | 100.00% | 5.63% |
| Q GLOBAL ADVISORS, LLC | 05/14/2025 | 170.79 K | $2.00 K | 0.00% | 4.98% |
| CLEAR STREET LLC | 05/15/2025 | 144.43 K | $2.09 K | -0.55% | 4.21% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 05/05/2025 | 122.01 K | $1.77 K | 0.00% | 3.56% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 108.75 K | $1.58 K | 0.00% | 3.17% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 05/15/2025 | 108.74 K | $1.58 K | 0.00% | 3.17% |
| PICTON MAHONEY ASSET MANAGEMENT | 05/07/2025 | 75.00 K | $1.00 K | 100.00% | 2.19% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 05/14/2025 | 75.00 K | $937 | 0.00% | 2.19% |
| TENOR CAPITAL MANAGEMENT CO., L.P. | 05/15/2025 | 50.00 K | $725 | 0.00% | 1.46% |
| PARALLEL ADVISORS, LLC | 04/08/2025 | 50.00 K | $725 | 100.00% | 1.46% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 05/14/2025 | 50.00 K | $725 | 0.00% | 1.46% |
| TABOR ASSET MANAGEMENT, LP | 05/05/2025 | 50.00 K | $725 | 100.00% | 1.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 05/12/2025 | 43.80 K | $635 | 0.00% | 1.28% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 05/15/2025 | 25.00 K | $362 | 0.00% | 0.73% |
| WHITEBOX ADVISORS LLC | 05/15/2025 | 23.25 K | $337 | -7.00% | 0.68% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 15.00 K | $217 | 0.00% | 0.44% |
| WALLEYE TRADING LLC | 05/14/2025 | 13.33 K | $193 | -81.05% | 0.39% |
| DUPONT CAPITAL MANAGEMENT CORP | 04/22/2025 | 12.50 K | $166 | 0.00% | 0.36% |
| CALAMOS ADVISORS LLC | 04/29/2025 | 12.50 K | $166 | 0.00% | 0.36% |
| SILVER ROCK FINANCIAL LP | 05/15/2025 | 12.22 K | $177 | 0.00% | 0.36% |
| ANCORA ADVISORS, LLC | 05/15/2025 | 2.50 K | $36 | 0.00% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CERo Therapeutics Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of CERo Therapeutics Holdings, Inc.. The most heavily invested institutionals were:
CANTOR FITZGERALD, L. P.: 441,048
MMCAP International Inc. SPC: 375,000
Saba Capital Management, L.P.: 295,913
PERISCOPE CAPITAL INC.: 274,000
Clear Street Derivatives LLC: 268,129
LINDEN ADVISORS LP: 249,999
98.55% of CERo Therapeutics Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.87 M shares in the last 24 months. This purchase volume represents approximately $146.06 K in transactions.